KRAS and neoplasm: Mutational analysis of the kinase domain of EGFR coding sequence (exons 18 to 21), exon 2 of K-RAS, exons 9 and 20 of PI3KCA, and exon 15 of B-RAF was performed in primary tumor, and in MT-CHC01 cell line.